A.34 Chronic Pancreatitis Flashcards
A.34 Chronic Pancreatitis
Chronic pancreatitis is progressive inflammation with irreversible damage to pancreatic structure and function (both exocrine and endocrine).
A.34 Chronic Pancreatitis
Etiology:
Main causes:
Alcohol abuse (60–70% of cases; especially men)
Pancreatic ductal obstruction (<10%; e.g., strictures from trauma or stones)
Tobacco use
Idiopathic pancreatitis (20–30%)
Hereditary pancreatitis (~1%; PRSS1 gene mutation, autosomal dominant, onset < 20 yrs)
Autoimmune pancreatitis
Systemic diseases:
- Severe hypertriglyceridemia (>1000 mg/dL)
- Primary hyperparathyroidism (hypercalcemia)
- Cystic fibrosis (~2% develop chronic pancreatitis)
Tropical pancreatitis: common in Tropics (esp. Southern India); young age at onset
A.34 Chronic Pancreatitis
Pathophysiology
- Autodigestion and Inflammation
Damage to pancreatic acinar cells (e.g., alcohol)
Outflow obstruction or premature activation of trypsinogen → trypsin
Intraparenchymal activation of digestive enzymes (amylase, lipase)
→ Autodigestion of pancreatic tissue → Inflammation - Fibrosis
Toxins/inflammatory mediators (e.g., alcohol, cytokines)
→ Activation of pancreatic stellate cells
→ Key contributors to pancreatic fibrosis - Pancreatic Insufficiency (from tissue atrophy + fibrosis)
Exocrine insufficiency → ↓ lipase, amylase, protease
→ Malabsorption, steatorrhea, maldigestion
Endocrine insufficiency → β-cell destruction
→ Pancreatic diabetes
A.34 Chronic Pancreatitis
Clinical Features
- Epigastric Abdominal Pain (main symptom)
Radiates to the back, relieved by bending forward
Worsens after eating
Initially episodic, later becomes persistent
Often with nausea and vomiting
In late stages, pain may be absent - Features of Pancreatic Insufficiency
Late manifestation (after ~90% of pancreas is destroyed)
Exocrine insufficiency signs:
Steatorrhea (fatty stools)
Cramping pain, bloating, diarrhea, weight loss
Can cause fat-soluble vitamin deficiencies (D, E, A, K)
Malabsorption and weight loss
Endocrine insufficiency signs:
Pancreatic diabetes (due to β-cell destruction)
A.34 Chronic Pancreatitis
Diagnostics (Imaging)
- Abdominal CT (plain + contrast)
Best initial test to screen for chronic pancreatitis
Detects:
Pancreatic atrophy
Ductal dilations
Ductal calcifications
“Chain of lakes” appearance
Can rule out pancreatic cancer or GI malignancy (esp. with epigastric pain + weight loss) - MRCP (Magnetic Resonance Cholangiopancreatography)
Used when CT is equivocal but clinical suspicion is high
Shows:
Ductal strictures and dilations
Pancreatic calcifications - Abdominal X-ray
Shows visible pancreatic calcifications
High specificity but low sensitivity (only seen in ~30% of cases) - Ultrasound (US)
Abdominal US:
Indistinct margins, pancreatic enlargement
Calcifications, ductal dilation/strictures, or stones
Endoscopic US:
Parenchymal lobularity, hyperechoic foci
Ductal dilation and calcification - ERCP (Endoscopic Retrograde Cholangiopancreatography)
Detects early disease and allows treatment (e.g., duct stenting)
Findings:
Ductal stones (seen as filling defects)
“Chain of lakes” / “string of pearls” (classic sign)
Irregularity and dilation of main pancreatic duct
A.34 Chronic Pancreatitis
Laboratory Tests:
- Serum pancreatic enzymes
Lipase = specific
Amylase = non-specific - Pancreatic Function Tests
Indirect tests:
Fecal elastase-1 (FE-1):
< 200 µg/g → pancreatic exocrine insufficiency
< 100 µg/g → severe exocrine insufficiency
72-hour fecal fat test:
Fecal fat > 7 g/day = diagnostic for steatorrhea
Direct tests:
CCK test, secretin test, CCK-secretin pancreatic function test
A.34 Chronic Pancreatitis
Genetic Testing:
Indications:
Family history of chronic pancreatitis
Young patients with idiopathic pancreatitis
Key genes:
PRSS1 mutation → hereditary pancreatitis
CFTR gene mutation → seen in ~40% of idiopathic cases
A.34 Chronic Pancreatitis
Treatment:
Avoid alcohol and nicotine
Diet:
Small, regular meals
High in carbohydrates, low in fat
Supplement with medium-chain triglycerides
Pancreatic enzyme replacement (with meals)
Fat-soluble vitamins (DEAK) – parenteral if needed
Insulin for endocrine insufficiency
Pain Management
Analgesics:
NSAIDs, opioids (e.g., fentanyl, morphine)
Low-dose tricyclic antidepressants (e.g., amitriptyline)
For intractable pain:
Celiac ganglion block (temporary relief)
Endoscopic papillotomy + ductal dilation + stenting, stone removal
ESWL (extracorporeal shock wave lithotripsy) for intraductal stones
Surgical Management
Indications:
Suspected pancreatic cancer
Intractable pain not responding to other treatments
Procedures:
Pancreaticojejunostomy (if duct > 5 mm)
Partial pancreatectomy (e.g., Whipple’s procedure)
Thoracoscopic bilateral splanchnicectomy
A.34 Chronic Pancreatitis
Complications:
- Pancreatic insufficiency
Due to fibrosis and acinar cell destruction
Leads to malabsorption and pancreatic diabetes - Pancreatic pseudocysts
Encapsulated fluid collections (develop ~4 weeks after acute attack)
Occur in both acute and chronic pancreatitis
Seen in ~10% of chronic cases
Wall is fibrous, not epithelial (unlike true cysts)
- Splenic vein thrombosis
Inflammation → thrombosis → left-sided portal hypertension
→ Risk of gastric varices - Pancreatic ascites
Caused by:
Ductal disruption (e.g., acute pancreatitis, trauma, surgery)
Pseudocyst rupture
→ Leakage of pancreatic fluid → ascites - Other complications:
Pancreatic abscess
Portal vein thrombosis
Pancreatic diabetes
Pancreatic cancer (esp. in hereditary pancreatitis)